Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G7 | Q13093 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 7/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6378459 | 0.86 | PLA2G7 (0.43) | PLA2G7MAOBPTPN1ENPP2APP | |
| SCHEMBL6380894 | 0.84 | MAOB (0.47) | PLA2G7MAOBPTPN1APPMAOA | |
| SCHEMBL6378028 | 0.82 | MMP13 (0.43) | PLA2G7POLBMAOBPTPN1ENPP2 | |
| SCHEMBL6383331 | 0.78 | MMP13 (0.54) | MAOBPTPN1APPMAOANR4A2 | |
| SCHEMBL6379256 | 0.72 | MMP13 (0.59) | MMP13MMP14CTSLCTSB | |
| SCHEMBL3504319 | 0.71 | RAB9A (0.53) | POLBMAPTMAOBMAOA | |
| SCHEMBL6379245 | 0.68 | CTSL (0.48) | MAOBPTPN1APPMAOANR4A2 | |
| SCHEMBL6378913 | 0.66 | MMP13 (0.56) | MAOBPTPN1APPMAOANR4A2 | |
| SCHEMBL6379044 | 0.66 | MMP13 (0.50) | MAOBPTPN1APPMAOANR4A2 | |
| SCHEMBL6378851 | 0.66 | MMP13 (0.47) | MAOBPTPN1APPMAOANR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1202974-B1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | PFIZER PROD INC (US) | 2005-11-09 | — | — | EP | disclosed |
| US-6579982-B1 | Treating inflammation, cancer | PFIZER INC. | 2003-06-17 | — | — | US | disclosed |
| EP-1202974-A1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | Pfizer Products Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001012611-A1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2001-02-22 | — | — | WO | disclosed |